Simendan (CAS 131741-08-7), C14H12N6O, the formula weight is 280.28, and its form is yellow liquid.
Simendan is suitable for traditional treatment (diuretics, angiotensin-converting enzyme inhibitors and digitalis), and it requires short-term treatment of acute decompensated heart failure (ADHF), which increases myocardial contractility.

Market Analysis and Insights: Global and China Simendan (CAS 131741-08-7) Market
This report focuses on global and China Simendan (CAS 131741-08-7) market.
In 2020, the global Simendan (CAS 131741-08-7) market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In China the Simendan (CAS 131741-08-7) market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Simendan (CAS 131741-08-7) Scope and Market Size
Simendan (CAS 131741-08-7) market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Simendan (CAS 131741-08-7) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Simendan (CAS 131741-08-7) market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
12.5mg/Vail
2.5mg/Vail

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Qilu Pharma
Shengnuo Biological Pharma
Livealth Biopharma
Orion Pharma
ACTIZA
AbbVie Pharma